ARX-305

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameARX-305
Drug Alias NameARX-305NCB-002JNJ-0631
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Non-cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Amberstatin269 payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) +[4] 
Mechanisms of ActionAnti-CD70Tubulin inhibitors
TargetsCD70 antigenTubulin
Therapy Area/IndicationsLymphomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAmbrx Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesZhejiang Xinma Biomedicine Co LtdAmbrx Inc
Inactive CompaniesN/A
Active IndicationsLymphomaNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A